AI assistant
Sending…
EROAD Limited — Capital/Financing Update 2017
Dec 15, 2017
66188_rns_2017-12-15_66d37af5-b3e5-4579-8ecc-c38ade907b90.pdf
Capital/Financing Update
Open in viewerOpens in your device viewer
==> picture [77 x 64] intentionally omitted <==
EROAD Limited – Placement Allotment
For the purposes of Listing Rule 7.12.1, EROAD Limited (NZX:ERD) advises that the following shares have been issued on 15 December 2017:
| (a) | Class of Security | Ordinary shares |
|---|---|---|
| ISIN: | NZERDE0001S5 | |
| (b) | Number issued: | 5,099,247 |
| (c) | Issue price: | $3.04 |
| (d) | Whether payment was in cash: | Yes |
| (e) | Any amount paid up: | In full |
| (f) | Principal terms of the Securities: | Not applicable |
| (g) | Percentage of the total Class of Securities issued: | 8.357% of the total number of |
| fully paid ordinary shares prior to | ||
| this issue | ||
| (h) | Reason for the issue: | Allotment of 5,099,247 ordinary |
| shares under a placement | ||
| conducted by EROAD Limited | ||
| (i) | Specific authority for the issue: | Directors’ resolutions dated 11 |
| December 2017 | ||
| (j) | Terms or details of the issue: | New ordinary shares which rank |
| equally with all other fully paid | ||
| ordinary shares in EROAD | ||
| Limited on issue | ||
| (k) | Total number of Securities of the Class in existence after the | 66,116,258 |
| issue: | ||
| (l) | Treasury Stock: | Not applicable |
| (m) | Date of issue: | 15 December 2017 |
ENDS
Contact: Michael Bushby, Chairman on +64 64 927 4747. For more information about EROAD visit our website www.eroad.com
More from EROAD Limited
Major Shareholding Notification
2026
May 28
Major Shareholding Notification
2026
May 27
Report Publication Announcement
2026
May 27
Share Issue/Capital Change
2026
May 27
Proxy Solicitation & Information Statement
2026
May 25
Earnings Release
2026
May 24
Report Publication Announcement
2026
May 24
Board/Management Information
2026
May 21
Report Publication Announcement
2026
Apr 29
Proxy Solicitation & Information Statement
2026
Apr 27